NeRRe Therapeutics
Develops clinical and PRE-clinical neurokinin receptor antagonists
Hertford, UKFounded 2012
Total raised
€17M
€16,727,272
Funding rounds
1
Investors
3
distinct backers
Active since
2012-11
latest 2012-11
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood18
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-12-01 | Series A | €17M | Advent Venture Partners,Novo A,S | View deal → |